These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 4559539)
1. 5-fluorocytosine in the treatment of mycotic infections. Vandevelde AG; Mauceri AA; Johnson JE Ann Intern Med; 1972 Jul; 77(1):43-51. PubMed ID: 4559539 [No Abstract] [Full Text] [Related]
2. 5-fluorocytosine in the treatment of cryptococcal and candida mycoses. Fass RJ; Perkins RL Ann Intern Med; 1971 Apr; 74(4):535-9. PubMed ID: 5551162 [No Abstract] [Full Text] [Related]
4. 5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience. Steer PL; Marks MI; Klite PD; Eickhoff TC Ann Intern Med; 1972 Jan; 76(1):15-22. PubMed ID: 5063168 [No Abstract] [Full Text] [Related]
5. Therapy of deep-seated fungal infections with 5-fluorocytosine. Firkin FC Aust N Z J Med; 1974 Oct; 4(5):462-7. PubMed ID: 4616675 [No Abstract] [Full Text] [Related]
6. Antimycotic activity of BAY N 7133 in animal experiments. Plempel M J Antimicrob Chemother; 1984 May; 13(5):447-63. PubMed ID: 6330018 [TBL] [Abstract][Full Text] [Related]
7. Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice. Polak A Chemotherapy; 1987; 33(5):381-95. PubMed ID: 2822362 [TBL] [Abstract][Full Text] [Related]
8. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. Van Cutsem J Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313 [TBL] [Abstract][Full Text] [Related]
9. 5-fluorocytosine: a replacement for amphotericin B in the treatment of candida and cryptococcus neoformans infections? Pankey GA; Lockwood WR; Montalvo JM J La State Med Soc; 1970 Dec; 122(12):365-9. PubMed ID: 5492591 [No Abstract] [Full Text] [Related]
10. Drug treatment of the systemic mycoses. Newberry WM Semin Drug Treat; 1972; 2(3):313-29. PubMed ID: 4617926 [No Abstract] [Full Text] [Related]
11. Treatment of systemic mycoses. Abernathy RS Medicine (Baltimore); 1973 Sep; 52(5):385-94. PubMed ID: 4725961 [No Abstract] [Full Text] [Related]
12. [Candida albicans meningitis in infancy. Pathogenesis, clinical aspects and chemotherapy]. Ströder J; Kühner U; Färber D Dtsch Med Wochenschr; 1975 May; 100(21):1196-9. PubMed ID: 1093833 [No Abstract] [Full Text] [Related]
13. [Chemotherapy of mycoses of the inner organs]. Scholer HJ Schweiz Med Wochenschr; 1968 Apr; 98(16):602-11. PubMed ID: 5688589 [No Abstract] [Full Text] [Related]
14. Use of 5-fluorocytosine in systemic candidiasis in infancy. Isacson M; Noah Z; Faber J; Herishano Y; Gottfried L Arch Dis Child; 1972 Dec; 47(256):954-9. PubMed ID: 4630479 [TBL] [Abstract][Full Text] [Related]
15. The in-vivo activity of an antifungal antibiotic, benanomicin A, in comparison with amphotericin B and fluconazole. Ohtsuka K; Watanabe M; Orikasa Y; Inouye S; Uchida K; Yamaguchi H; Kondo S; Takeuchi T J Antimicrob Chemother; 1997 Jan; 39(1):71-7. PubMed ID: 9044030 [TBL] [Abstract][Full Text] [Related]
16. Effect of 5-fluorocytosine and amphotericin B on Candida albicans infection in mice. Rabinovich S; Shaw BD; Bryant T; Donta ST J Infect Dis; 1974 Jul; 130(1):28-31. PubMed ID: 4601179 [No Abstract] [Full Text] [Related]
18. [Fungal infections in children with malignant disease]. Michel G Arch Pediatr; 2011 May; 18 Suppl 1():S3-7. PubMed ID: 21596284 [TBL] [Abstract][Full Text] [Related]
19. [Commonly used antifungal agents in the treatment of systemic mycoses]. Berenguer Berenguer J Rev Clin Esp; 1995 Oct; 195 Suppl 3():58-65. PubMed ID: 9441308 [No Abstract] [Full Text] [Related]
20. Antifungal agents used for deep-seated mycotic infections. Hermans PE; Keys TF Mayo Clin Proc; 1983 Apr; 58(4):223-31. PubMed ID: 6339832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]